1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hong Kong Pharmaceuticals and Healthcare Report Q1 2016

Hong Kong Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 101 pages

Includes 3 FREE quarterly updates

BMI View: Regulatory delays will impinge upon the access that drugmakers have to Hong Kong'spharmaceutical market. With a drug approval time of more than 18 months, the administrative region lagsbehind peers such as Singapore where full evaluation takes approximately nine months. Additionally, ashealthcare costs escalate, getting listed on Hong Kong's formulary will become increasing challenging,especially for high-value treatments, giving rise to risk sharing arrangements.

Headline Expenditure Projections
- Pharmaceuticals: HKD12.07bn (USD1.56bn) in 2014 to HKD12.95bn (USD1.67bn) in 2015; +7.3% inlocal currency and 7.0% US dollars terms. Forecast unchanged from previous quarter.
- Healthcare: HKD131.75bn (USD16.99bn) in 2014 to HKD141.63bn (USD18.23bn) in 2015; +7.5% inlocal currency and 7.3% in US dollars terms. Forecast unchanged from previous quarter.

Table Of Contents

Hong Kong Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Hong Kong 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 23
OTC Medicine Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2013-2019) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2013-2019) 29
Industry Risk Reward Index 30
Asia Pacific Risk/Reward Index 30
Hong Kong Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Table: Processed Applications 40
Intellectual Property Issues 43
Pricing And Reimbursement Regime 44
Table: Number Of Drugs In Drug Formulary 45
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Hong Kong 2009-2014) 50
Table: Healthcare Personnel (Hong Kong 2009-2014) 50
Table: Healthcare Activity (Hong Kong 2009-2014) 51
Clinical Trials 59
Table: Top Causes Of Deaths In Hong Kong 62
Competitive Landscape 63
Research-Based Industry 63
Table: Multinational Market Activity 65
Pharmaceutical Supply Chain 66
Pharmaceutical Retail Sector 67
Company Profile 69
Wuyi International Pharmaceutical 69
CK Life Sciences 72
GlaxoSmithKline 76
Pfizer 79
Sanofi 82
Merck and Co 85
Novartis 87
Demographic Forecast 90
Table: Population Headline Indicators (Hong Kong 1990-2025) 91
Table: Key Population Ratios (Hong Kong 1990-2025) 91
Table: Urban/Rural Population and Life Expectancy (Hong Kong 1990-2025) 92
Table: Population By Age Group (Hong Kong 1990-2025) 92
Table: Population By Age Group % (Hong Kong 1990-2025) 93
Glossary 95
Methodology 97
Pharmaceutical Expenditure Forecast Model 97
Healthcare Expenditure Forecast Model 97
Notes On Methodology 98
Risk/Reward Index Methodology 99
Index Overview 100
Table: Pharmaceutical Risk/Reward Index Indicators 100
Indicator Weightings 101

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.